GKOSNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
GLAUKOS Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$166.96+2.12 (+1.29%)
Close on Oct 19, 2026
- Market cap
- $9.82B
- P/E (TTM)
- –
- Dividend yield
- –
Glaukos statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Glaukos | Industry median |
|---|---|---|
| Market Cap | $9.85B | $230.55M |
| Enterprise Value | $9.73B | $202.97M |
| PS Ratio | 16.07 | 3.11 |
| PB Ratio | 14.43 | 3.14 |
| P/TBV Ratio | 20.15 | 4.57 |
Enterprise value
| Measure | Glaukos | Industry median |
|---|---|---|
| EV / Sales | 15.88 | 2.92 |
Income (trailing twelve months)
| Measure | Glaukos | Industry median |
|---|---|---|
| Revenue | $612.84M | $102.39M |
| Gross Profit | $372.02M | $60.36M |
| Operating Income | -$193.36M | -$4.31M |
| Pretax Income | -$192.83M | -$2.26M |
| Net Income | -$188.05M | -$6.57M |
| EBITDA | -$151.39M | -$1.98M |
| EPS (Diluted) | -$3.25 | -$0.07 |
Margins
| Measure | Glaukos | Industry median |
|---|---|---|
| Gross Margin | 60.7% | 55.1% |
| Operating Margin | -31.6% | -6.04% |
| Pretax Margin | -31.5% | -4.11% |
| Profit Margin | -30.7% | -10.5% |
| EBITDA Margin | -24.7% | -2.67% |
| FCF Margin | -1.99% | -0.30% |
Returns
| Measure | Glaukos | Industry median |
|---|---|---|
| Return on Equity (ROE) | -26.0% | -19.2% |
| Return on Assets (ROA) | -19.7% | -13.3% |
| Return on Invested Capital (ROIC) | -24.9% | -4.11% |
| Return on Capital Employed (ROCE) | -23.6% | -9.07% |
Growth
| Measure | Glaukos | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 41.5% | 8.85% |
| Revenue Growth (3Y CAGR) | 21.5% | 7.08% |
| Revenue Growth (5Y CAGR) | 17.7% | 11.8% |
Balance sheet
| Measure | Glaukos | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $114.49M | $37.33M |
| Net Cash (Debt) | $114.49M | $3.92M |
| Net Cash Per Share | $1.94 | $0.28 |
| Equity (Book Value) | $682.49M | $57.36M |
| Book Value Per Share | $11.57 | $2.81 |
| Tangible Book Value | $488.63M | $10.71M |
| Working Capital | $413.45M | $54.64M |
Financial position
| Measure | Glaukos | Industry median |
|---|---|---|
| Current Ratio | 5.04 | 2.50 |
| Quick Ratio | 2.48 | 1.54 |
| Interest Coverage | -39.42 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Glaukos | Industry median |
|---|---|---|
| Operating Cash Flow | -$950.00K | -$653.46K |
| Capital Expenditures | -$11.25M | -$3.69M |
| Free Cash Flow | -$12.20M | -$835.02K |
| FCF Per Share | -$0.21 | -$0.02 |
Efficiency
| Measure | Glaukos | Industry median |
|---|---|---|
| Asset Turnover | 0.64 | 0.59 |
| Inventory Turnover | 2.07 | 2.21 |
| Revenue Per Employee | $560.18K | $322.57K |
| Profits Per Employee | -$171.89K | -$51.88K |
| Employee Count | 1,094 | 185 |
Dividends and yields
| Measure | Glaukos | Industry median |
|---|---|---|
| Earnings Yield | -1.91% | -6.91% |
| FCF Yield | -0.12% | -0.56% |
Shares
| Measure | Glaukos | Industry median |
|---|---|---|
| Shares Outstanding | 58,983,900 | 44,856,700 |
| Shares Change (YoY) | 3.23% | 3.35% |
| Shares Change (QoQ) | 0.86% | 0.27% |
| Float | 55,835,500 | 37,097,900 |
| Shares Held by Insiders | 5.34% | 10.6% |
| Shares Held by Institutions | 103.1% | 63.5% |
Taxes
| Measure | Glaukos | Industry median |
|---|---|---|
| Income Tax | -$4.79M | $1.52M |
Scores
| Measure | Glaukos | Industry median |
|---|---|---|
| Altman Z-Score | 23.86 | 1.95 |
| Piotroski F-Score | 3 | 5 |
| Beneish M-Score | -3.02 | -2.64 |
Calculated by StockData from Glaukos's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.